Fluoroquinolones in the Treatment of Tuberculosis: Which Is Best?
Author:
Publisher
American Thoracic Society
Subject
Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference15 articles.
1. Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data
2. Population Pharmacokinetics of Levofloxacin, Gatifloxacin, and Moxifloxacin in Adults with Pulmonary Tuberculosis
3. Reevaluation of Moxifloxacin Pharmacokinetics and Their Direct Effect on the QT Interval
4. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in Diagnostics and Drug Discovery against Resistant and Latent Tuberculosis Infection;Pharmaceutics;2023-09-30
2. In Vitro and In Vivo Activity of Gepotidacin against Drug-Resistant Mycobacterial Infections;Antimicrobial Agents and Chemotherapy;2022-12-20
3. Treatment options for children with multi-drug resistant tuberculosis;Expert Review of Clinical Pharmacology;2022-11-27
4. In vitro and in vivo activity of Gepotidacin against drug-resistant mycobacterial infections;2022-08-20
5. Role of Antimicrobial Peptides in Treatment and Prevention of Mycobacterium Tuberculosis: A Review;International Journal of Peptide Research and Therapeutics;2022-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3